DE1484727U - - Google Patents

Info

Publication number
DE1484727U
DE1484727U DENDAT1484727D DE1484727DU DE1484727U DE 1484727 U DE1484727 U DE 1484727U DE NDAT1484727 D DENDAT1484727 D DE NDAT1484727D DE 1484727D U DE1484727D U DE 1484727DU DE 1484727 U DE1484727 U DE 1484727U
Authority
DE
Germany
Prior art keywords
ttt
mmt
tmt
iii
ttttt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1484727D
Other languages
German (de)
English (en)
Publication of DE1484727U publication Critical patent/DE1484727U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1484727D Active DE1484727U (enExample)

Publications (1)

Publication Number Publication Date
DE1484727U true DE1484727U (enExample)

Family

ID=789914

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1484727D Active DE1484727U (enExample)

Country Status (1)

Country Link
DE (1) DE1484727U (enExample)

Similar Documents

Publication Publication Date Title
Yuan et al. Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
Oladipo et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
Rini et al. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
Deraco et al. Consensus statement on peritoneal mesothelioma
BRPI0516407A (pt) agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
Cullen et al. The 111 study: a single-arm, phase 3 trial evaluating one cycle of bleomycin, etoposide, and cisplatin as adjuvant chemotherapy in high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis
US10416162B2 (en) Her2 diagnostic methods
Krieg et al. CXCR4-A prognostic and clinicopathological biomarker for pancreatic ductal adenocarcinoma: A Meta-Analysis
Jonker et al. The influence of hospital volume on long-term oncological outcome after rectal cancer surgery
MX2009012344A (es) Derivacion reversible de poli(aril eter cetonas).
DE1484727U (enExample)
JP2012512858A5 (enExample)
CN102713606A (zh) 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法
Stevens et al. Innovative, combinatorial and high-throughput approaches to degrader synthesis
ES3019008T3 (en) Predicting peptide receptor radiotherapy using a gene expression assay
Tejpar et al. Integrating biomarkers in colorectal cancer trials in the West and China
MacConmara et al. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma
Nishiwada et al. Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma
Veloudis et al. Assessing the clinical utility of Wnt pathway markers in colorectal cancer
Zhao et al. Lymph node yield as a measure of pancreatic cancer surgery quality
Riddy Update on the prevalence of anthelmintic resistance 2021–2022
Yao et al. How to reduce the early anastomotic complications of laparoscopic low anterior rectal resection? A video vignette.
Boroojerdi et al. Staining pattern of specific and cross‐reacting Melan‐A antibodies: A comparative study on 15,840 samples from 133 human tumor types
Kakegawa et al. A new technique for esophageal reconstruction by combined skin and muscle flaps after failure in primary colonic interposition.
US20190383820A1 (en) Detecting cancer stem cells using a glycan biomarker